Company · CIK 1616212
Trillium Therapeutics Inc.
| CIK | 1616212 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | A1 |
| Business address | Ontario, Canada |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2015-03-24 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-224983 | 2018-05-16 | 2021-11-19 | 3 | |
| 333-237810 | 2020-04-23 | 2021-11-19 | 7 | |
| 333-254443 | 2021-03-18 | 2021-03-18 | 1 | |
| 333-202665 | 2015-03-11 | 2015-04-01 | 5 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2021-11-19 | EFFECTDeclared effective | 333-237810 | 9999999995-21-004415 |
| 2021-11-19 | EFFECTDeclared effective | 333-224983 | 9999999995-21-004414 |
| 2021-03-18 | S-3ASRShelf registered | 333-254443 | 0001104659-21-038375 |
| 2020-09-11 | 424B5Shelf takedown | 333-237810 | 0001062993-20-004468 |
| 2020-09-09 | 424B5Shelf takedown | 333-237810 | 0001062993-20-004414 |
| 2020-09-09 | 424B5Shelf takedown | 333-237810 | 0001062993-20-004398 |
| 2020-05-05 | 424B5Shelf takedown | 333-237810 | 0001062993-20-002136 |
| 2020-05-04 | EFFECTDeclared effective | 333-237810 | 9999999995-20-001027 |
| 2020-04-23 | F-3Shelf registered | 333-237810 | 0001062993-20-001914 |
| 2018-05-31 | EFFECTDeclared effective | 333-224983 | 9999999995-18-001393 |
| 2018-05-16 | F-3Shelf registered | 333-224983 | 0001062993-18-002283 |
| 2018-01-08 | EFFECTDeclared effective | 333-222085 | 9999999995-18-000073 |
| 2015-06-05 | EFFECTDeclared effective | 333-204551 | 9999999995-15-001552 |
| 2015-04-01 | 424B1Final prospectus | 333-202665 | 0001193125-15-116323 |
| 2015-03-31 | EFFECTDeclared effective | 333-202665 | 9999999995-15-000748 |
| 2015-03-31 | F-1/AAmendment | 333-202665 | 0001193125-15-112339 |
| 2015-03-25 | F-1/AAmendment | 333-202665 | 0001193125-15-105201 |
| 2015-03-11 | F-1Registration filed | 333-202665 | 0001193125-15-087567 |